TrianglePUBLICATIONS · 35562406
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2022 Jul
- First author
- Ferreri AJM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ferreri AJM
- type
- Author
- name
- Cwynarski K
- type
- Author
- name
- Pulczynski E
- type
- Author
- name
- Fox CP
- type
- Author
- name
- Schorb E
- type
- Author
- name
- Celico C
- type
- Author
- name
- Falautano M
- type
- Author
- name
- Nonis A
- type
- Author
- name
- La Rosée P
- type
- Author
- name
- Binder M
- type
- Author
- name
- Fabbri A
- type
- Author
- name
- Ilariucci F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ferreri AJM
- type
- Author
- name
- Cwynarski K
- type
- Author
- name
- Pulczynski E
- type
- Author
- name
- Fox CP
- type
- Author
- name
- Schorb E
- type
- Author
- name
- Celico C
- type
- Author
- name
- Falautano M
- type
- Author
- name
- Nonis A
- type
- Author
- name
- La Rosée P
- type
- Author
- name
- Binder M
- type
- Author
- name
- Fabbri A
- type
- Author
- name
- Ilariucci F
- type
- Author
- bibliography ids
- nci-bib-82ca127a1e87b18cd395d28c
- book metadata
- content sha256
- 2c3d164830b0275af91dfbbbff82651064fbf4549b188ca13054a306bdbb82b2
- document type
- citation
- dois
- 10.1038/s41375-022-01582-5
- electronic publication date
- display
- 2022 May 13
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35562406
- immutable id
- pubmed:35562406@2c3d164830b0275af91dfbbbff82651064fbf4549b188ca13054a306bdbb82b2
- journal
- abbreviation
- Leukemia
- issn electronic
- 1476-5551
- issn print
- 0887-6924
- issue
- 7
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 1870-1878
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35562406
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 43723b103ea27e92c44be1125b63421faaf39c7e9e979ba2abd52852d5153be7
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Jul
- precision
- month
- year
- 2022
- publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Preserved source evidence · Not medical advice